A limitation in the systemic uptake of many inhalable drugs is the restricted permeation through the pulmonary epithelial layer barrier. One strategy to bypass the epithelial layer when delivering non-permeable drugs is to alter the paracellular transport, allowing the uptake of drugs into the systemic circulation. In this study, the potential of sodium decanoate (Na dec), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) as absorption enhancers has been investigated to increase pulmonary paracellular permeability by modulating epithelial cells’ tight junctions. By incorporating Na dec, DHA and EPA, separately, into a nebulising formulation, the aim was to enhance the absorption of a fluorescent marker (flu-Na, used as model drug) across pulmonary epithelial cells (Calu-3). Results indicate that the aerosol performance of all the nebulizing formulations containing absorption enhancers was significantly better than control. Furthermore, the in vitro cell assays demonstrated a significant increase in paracellular transport of the fluorescent marker with Na dec and DHA formulations. This finding supports the potential use of DHA and Na dec to enhance epithelial transport of poorly permeable drugs delivered via inhalation.

The use of fatty acids as absorption enhancer for pulmonary drug delivery

Pacciana, Cristina;Colombo, Gaia;Traini, Daniela
Ultimo
2018

Abstract

A limitation in the systemic uptake of many inhalable drugs is the restricted permeation through the pulmonary epithelial layer barrier. One strategy to bypass the epithelial layer when delivering non-permeable drugs is to alter the paracellular transport, allowing the uptake of drugs into the systemic circulation. In this study, the potential of sodium decanoate (Na dec), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) as absorption enhancers has been investigated to increase pulmonary paracellular permeability by modulating epithelial cells’ tight junctions. By incorporating Na dec, DHA and EPA, separately, into a nebulising formulation, the aim was to enhance the absorption of a fluorescent marker (flu-Na, used as model drug) across pulmonary epithelial cells (Calu-3). Results indicate that the aerosol performance of all the nebulizing formulations containing absorption enhancers was significantly better than control. Furthermore, the in vitro cell assays demonstrated a significant increase in paracellular transport of the fluorescent marker with Na dec and DHA formulations. This finding supports the potential use of DHA and Na dec to enhance epithelial transport of poorly permeable drugs delivered via inhalation.
2018
Ghadiri, Maliheh; Canney, Finbarr; Pacciana, Cristina; Colombo, Gaia; Young, Paul M.; Traini, Daniela
File in questo prodotto:
File Dimensione Formato  
GHADIRI et al., The use of fatty acids (2018).pdf

solo gestori archivio

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 615.27 kB
Formato Adobe PDF
615.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
pagination_IJP_17325.pdf

solo gestori archivio

Descrizione: post print
Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 950.9 kB
Formato Adobe PDF
950.9 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Preprint_11392-2391264.pdf

accesso aperto

Descrizione: versione preprint
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2391264
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact